Literature DB >> 15308889

Gynecomastia and antihypertensive therapy.

Ari Mosenkis1, Raymond R Townsend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15308889      PMCID： PMC8109613          DOI： 10.1111/j.1524-6175.2004.3735.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Aldosterone blockade and heart failure.

Authors:  Mariell Jessup
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

2.  Pathophysiology of spironolactone-induced gynecomastia.

Authors:  L I Rose; R H Underwood; S R Newmark; E S Kisch; G H Williams
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

3.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

4.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 5.  Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.

Authors:  Tera D Moore; James J Nawarskas; Joe R Anderson
Journal:  Heart Dis       Date:  2003 Sep-Oct
  5 in total
  7 in total

1.  Gynecomastia.

Authors:  Frank Q Nuttall
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

Review 2.  Male gynecomastia.

Authors:  Bridgett A Haynes; Farouk Mookadam
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

Review 3.  Gynecomastia and hypertension.

Authors:  L Michael Prisant; Edward Chin
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

Review 4.  A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.

Authors:  Sandra Korol; Fannie Mottet; Sylvie Perreault; William L Baker; Michel White; Simon de Denus
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 5.  Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Authors:  Alessandro Cannavo; Leonardo Bencivenga; Daniela Liccardo; Andrea Elia; Federica Marzano; Giuseppina Gambino; Maria Loreta D'Amico; Claudia Perna; Nicola Ferrara; Giuseppe Rengo; Nazareno Paolocci
Journal:  Oxid Med Cell Longev       Date:  2018-09-19       Impact factor: 6.543

Review 6.  The renin-angiotensin-aldosterone system and its suppression.

Authors:  Marisa K Ames; Clarke E Atkins; Bertram Pitt
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

Review 7.  The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy.

Authors:  Luxitaa Goenka; Raghavan Padmanaban; Melvin George
Journal:  Curr Clin Pharmacol       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.